Noncovalent interaction between amyloid-β-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry

Journal of the American Society for Mass Spectrometry

Volumn 17, Issue 4, 2006, Pages 568-575

  Bazoti, Fotini N ^a,c   Bergquist, Jonas ^b   Markides, Karin E ^b   Tsarbopoulos, Anthony ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UPPSALA UNIVERSITY   (Sweden)

^c Goulandris Natural History Museum   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; DISEASES; FREE RADICALS; IONIZATION; MASS SPECTROMETRY; NEUROLOGY;

ALZHEIMER'S DISEASE; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; OLEUROPEIN; PEPTIDE;

POLYPEPTIDES;

AMYLOID BETA PROTEIN[1-40]; ANTIOXIDANT; LIGAND; OLEUROPEIN; ORGANIC SOLVENT;

ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; PH; PROTEIN INTERACTION;

AMYLOID BETA-PROTEIN; ANTIOXIDANTS; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MACROMOLECULAR SUBSTANCES; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEIN BINDING; PYRANS; SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33645125772     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2005.11.016     Document Type: Article

References (50)

1. D.J. Selkoe Alzheimer's Disease Genes, Proteins, and Therapy Physiol. Rev. 81 2 2001 741 766
2. D.J. Selkoe Alzheimer's Disease Genotypes, Phenotypes, and Treatments Science 275 1997 630 631
3. E.H. Koo, P.T. Lansbury Jr, J.W. Kelly Amyloid Diseases Abnormal Protein Aggregation in Neurodegeneration Proc. Natl. Acad. Sci. U.S.A. 96 1999 9989 9990
4. W.R. Markesbery Oxidative Stress Hypothesis in Alzheimer's Disease Free Radical Biol. Med. 23 1997 134 147
5. A.B. Glippingdale, J.D. Wade, C.J. Barrow The Amyloid-β-Peptide and Its Role in Alzheimer's Disease J. Peptide Sci. 7 2001 227 249
6. S. Varadarajan, S. Yatin, M. Aksenova, A.D. Butterfield Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity J. Struct. Biol. 130 2000 184 208
7. C. Behl Alzheimer's Disease and Oxidative Stress Implications for Novel Therapeutic Approaches Prog. Neurobiol. 57 1999 301 323
8. M. Grundman, M. Grundman, P. Delaney Antioxidant Strategies for Alzheimer's Disease Proc. Nutr. Soc. 61 2002 191 202
9. W.R. Markesbery, J.M. Carney Oxidative Alterations in Alzheimer's Disease Brain Pathol. 9 1999 133 146
10. P.L. McGeer, M. Schulzer, E.G. McGeer Arthritis and Anti-Inflammatory Agents as Possible Protective Factors for Alzheimer's Disease A Review of 17 Epidemiologic Studies Neurology 47 1996 425 432
11. J. Walter, C. Haass Secretases as Targets for β-Amyloid Lowering Drugs Drug Dev. Res. 56 2002 201 210
12. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan, D.J. Selkoe Amyloid-β Oligomers Their Production, Toxicity, and Therapeutic Inhibition Biochem. Soc. Trans. 30 2002 552 557
13. V. Chesneau, K. Verkellis, M.R. Rosner, D.J. Selkoe Purified Recombinant Insulin-Degrading Enzyme Degrades Amyloid β-Protein but Does Not Promote Its Oligomerization Biochem. J. 351 2000 509 516
14. D.K. Lahiri, M.R. Farlow, N.H. Greig, K. Sambamurti Current Drug Targets for Alzheimer's Disease Treatment Drug. Dev. Res. 56 2002 267 281
15. D.J. Selkoe Deciphering the Genesis and Fate of Amyloid β-Protein Yields Novel Therapies for Alzheimer Disease J. Clin. Invest. 110 2002 1375 1381
16. P.T. Lansbury Jr Back to the Future The "Old-Fashioned" Way to New Medications for Neurodegeneration Nat. Rev. Neurosci. 5 2004 S51 S57
17. P.T. Lansbury Jr Following Nature's Anti-Amyloid Strategy Nat. Biotechnol. 19 2001 112 113
18. G.M. Rishton, D.M. Retz, P.A. Tempest, J. Novotny, S. Kahn, J.J.S. Treanor, J.D. Lile, M. Citron Fenchylamine Sulfonamide Inhibitors of Amyloid β Peptide Production by the γ-Secretase Proteolytic Pathway Potential Small-Molecule Therapeutic Agents for the Treatment of Alzheimer's Disease J. Med. Chem. 43 2000 2297 2299
19. P. Kuner, B. Bohrmann, L.O. Tjernberg, J. Näslund, G. Huber, S. Celenk, F. Grüninger-Leitch, J.G. Richards, R. Jakob-Rötne, J.A. Kemp, C. Nordstedt Controlling Polymerization of β-Amyloid and Prion-Derived Peptides with Synthetic Small Molecule Ligands J. Biol. Chem. 275 2000 1673 1678
20. D.J. Douglas, B.A. Collings, S. Numao, V.J. Nesatyy Detection of Noncovalent Complex Between α-Amylase and Its Microbial Inhibitor Tendamistat by Electrospray Ionization Mass Spectrometry Rapid Commun. Mass Spectrom. 15 2001 89 96
21. F.N. Bazoti, A. Tsarbopoulos, K.E. Markides, J. Bergquist Study of the Noncovalent Interaction Between Amyloid-β-Peptide and Melatonin Using Electrospray Ionization Mass Spectrometry J. Mass Spectrom. 40 2005 182 192
22. M.J.R. Howes, N.S.L. Perry, P. Houghton Plants with Traditional Uses and Activities Relevant to the Management of Alzheimer's Disease and Other Cognitive Disorders J. Phytother. Res. 17 2003 1 18
23. B. Moosmann, C. Behl The Antioxidant Neuroprotective Effects of Estrogens and Phenolic Compounds are Independent from their Estrogenic Properties Proc. Natl. Acad. Sci. U.S.A. 96 1999 8867 8872
24. J.B. German, R.L. Walzem The Health Benefits of Wine Annu. Rev. Nutr. 20 2000 561 593
25. F. Visioli, A. Poli, C. Galli Antioxidant and Other Biological Activities of Phenols from Olives and Olive Oil Med. Res. Rev. 22 2002 65 75
26. F. Visioli, S. Bellosta, C. Galli Oleuropein, the Bitter Principle of Olives, Enhances Nitric Oxide Production by Mouse Macrophages Life. Sci. 62 1998 541 546
27. M.A. Carluccio, L. Siculella, M.A. Ancora, M. Massaro, E. Scoditti, C. Storelli, F. Visioli, A. Distante, R. De Caterina Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation Antiatherogenic Properties of Mediterranean Diet Phytochemicals Arterioscler. Thromb. Vasc. Biol. 23 2003 622 629
28. H.P. Fleming, W.M. Walter Jr, J.L. Etchells Antimicrobial Properties of Oleuropein and Products of Its Hydrolysis from Green Olives Appl. Microbiol. 26 1973 777 782
29. R.W. Owen, A. Giacosa, W.E. Hull, R. Haubner, G. Würtele, B. Spiegelhalder, H. Bartsch Olive Oil Consumption and Health The Possible Role of Antioxidants Lancet Oncol. 1 2000 107 112
30. T.E. Golde, C.B. Eckman Cholesterol Modulation as an Emerging Strategy for the Treatment of Alzheimer's Disease Drug Discov. Today 6 2001 1049 1055
31. A. Hofman, A. Ott, M.M.B. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp, C.N. van Duijn, C. Van Broeckhoven, D.E. Grobbee Atherosclerosis, Apolipoprotein E, and Prevalence of Dementia and Alzheimer's Disease in the Rotterdam Study Lancet 349 1997 151 154
32. L.M. Refolo, B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, G.S. Tint, K. Sambamurti, K.E. Duff, M.A. Pappolla Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model Neurobiol. Dis. 7 2000 321 331
33. L.M. Refolo, M.A. Pappolla, J. LaFrancois, B. Malester, S.D. Schmidt, T. Thomas-Bryant, G.S. Tint, R. Wang, M. Mercken, S.S. Petanceska, K.E. Duff A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease Neurobiol. Dis. 8 2001 890 899
34. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, D.A. Drachman Statins and the Risk of Dementia Lancet 356 2000 1627 1631
35. K. Heininger A Unifying Hypothesis of Alzheimer's Disease. II. Pathophysiological Processes Hum. Psychopharmacol. Clin. Exp. 14 1999 525 581
36. W.F. Stewart, C. Kawas, M. Corrada, E.J. Metter Risk of Alzheimer's Disease and Duration of NSAID Use Neurology 48 1997 626 632
37. S. Lee-Huang, L. Zhang, P. Lin Huang, Y.T. Chang, P.L. Huang Anti-HIV Activity of Olive Leaf Extract (OLE) and Modulation of Host Cell Gene Expression by HIV-1 Infection and OLE Treatment Biochem. Biophys. Res. Commun. 307 2003 1029 1037
38. C. Puel, A. Quintin, A. Agalias, J. Mathey, C. Obled, A. Mazur, M.J. Davicco, P. Lebecque, A.L. Skaltsounis, V. Coxam Olive Oil and Its Main Phenolic Micronutrient (Oleuropein) Prevent Inflammation-Induced Bone Loss in the Ovariectomized Rat Br. J. Nutr. 92 2004 119 127
39. T. Hashimoto, M. Ibi, K. Matsuno, S. Nakashima, T. Tanigawa, T. Yoshikawa, C. Yabe-Nishimura An Endogenous Metabolite of Dopamine, 3,4-Dihydroxyphenylethanol, Acts as a Unique Cytoprotective Agent Against Oxidative Stress-Induced Injury Free Rad. Biol. Med. 36 2004 555 564
40. J.A. Loo Electrospray Ionization Mass Spectrometry A Technology for Studying Noncovalent Macromolecular Complexes Int. J. Mass Spectrom. 200 2000 175 186
41. B.N. Pramanik, A.K. Ganguly, M.L. Gross Applied Electrospray Mass Spectrometry 2002 Marcel Dekker New York 361
42. B. Shasha, J. Leibowityz On the Oleuropein, the Bitter Principle of Olives J. Org. Chem. 26 1961 1948 1954
43. C.L. Shen, R.M. Murphy Solvent Effects on Self-Assembly of β-Amyloid Peptide Biophys. J. 69 1995 640 651
44. A.K. Ganguly, B.N. Pramanik, E. Huang, A. Tsarbopoulos, V.M. Girijavallabhan, S. Liberles Studies of the Ras-GDP and Ras-GTP Noncovalent Interactions Tetrahedron 49 36 1993 7985 7996
45. M. Palmblad, A. Westlind-Danielsson, J. Bergquist Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide (1-40) oligomers J. Biol. Chem. 277 2002 19506 19510
46. J. Naslund, A. Schierhorn, U. Hellman, L. Lanfelt, A.D. Roses, L.O. Tjernberg, J. Siberring, S.E. Gandy, B. Winblad, P. Greengard, C. Nordstedt, L. Terenius Relative Abundance of Alzheimer's Aβ Amyloid Peptide Variants in Alzheimer Disease and Normal Aging Proc. Natl. Acad. Sci. U.S.A. 91 1994 8378 8382
47. C. Schoneich, F. Zhao, K.P. Madden, K. Bobrowski Side Chain Fragmentation of N-Terminal Threonine or Serine Residue Induced Through Intramolecular Proton Transfer to Hydroxy Sulfuranyl Radical Formed at Neighboring Methionine in Dipeptides J. Am. Chem. Soc. 116 1994 4641 4652
48. G.P. Dado, S.H. Gellman Redox Control of Secondary Structure in a Designed Peptide J. Am. Chem. Soc. 115 1994 12609 12610
49. D.J. Selkoe Alzheimer's Disease A Central Role for Amyloid J. Neuropathol. Exp. Neurol. 53 1994 438 447
50. X.G. Chen, S.K. Brining, V.Q. Nguyen, A.L. Yergey Simultaneous Assessment of Conformation and Aggregation of β-Amyloid Peptide Using Electrospray Ionization Mass Spectrometry FASEB J. 11 1997 817 823